PMID- 21376840 OWN - NLM STAT- MEDLINE DCOM- 20120118 LR - 20161222 IS - 1556-3871 (Electronic) IS - 1547-5271 (Linking) VI - 8 IP - 8 DP - 2011 Aug TI - Functional characterization of the LQT2-causing mutation R582C and the associated voltage-dependent fluorescence signal. PG - 1273-80 LID - 10.1016/j.hrthm.2011.02.035 [doi] AB - BACKGROUND: The R582C mutation is one of many Long-QT Syndrome type 2 (LQT2)-causing mutations localized to the human ether-a-go-go related gene (hERG) channel's S5-P linker subdomain, yet its specific mechanism of dysfunction has not been examined. OBJECTIVE: This study sought to characterize the biophysical properties of the congenital LQT2-causing mutation, R582C, and utilize this mutation to provide the first report of voltage-dependent fluorescence from the S5-P linker. METHODS: Properties of the R582C channels were characterized by heterologous expression in both HEK293 cells and Xenopus oocytes using a combination of patch-clamp, 2-electrode voltage-clamp, immunoblot assay, and voltage-clamp fluorimetry. RESULTS: Expression of hERG R582C was found to be deficient in HEK293 cells, yet was amenable to rescue by incubation at reduced temperature or by treatment with dofetilide. Rescued channels expressed at levels comparable to wild type (WT) channels. Kinetic differences result in decreased outward repolarizing current evoked by an action potential clamp protocol. Voltage-clamp fluorimetry experiments utilized the introduced cysteine to covalently attach a fluorescent probe (tetramethylrhodamine-5-maleimide) to the S5-P linker to directly observe conformational changes occurring due to inactivation. CONCLUSION: The major mechanism underlying pathogenicity of the R582C mutation is a trafficking deficiency, although channels also exhibit kinetic deficiencies, perhaps reflecting the position of the mutation in the pore turret. Voltage clamp fluorescence signals from R582C channels provide evidence that the hERG turret undergoes distinct conformational changes during inactivation. CI - Copyright (c) 2011 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved. FAU - Fougere, Robert R AU - Fougere RR AD - Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada. fedida@interchange.ubc.ca FAU - Es-Salah-Lamoureux, Zeineb AU - Es-Salah-Lamoureux Z FAU - Rezazadeh, Saman AU - Rezazadeh S FAU - Eldstrom, Jodene AU - Eldstrom J FAU - Fedida, David AU - Fedida D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110303 PL - United States TA - Heart Rhythm JT - Heart rhythm JID - 101200317 RN - 0 (DNA, Complementary) RN - 0 (ERG1 Potassium Channel) RN - 0 (Ether-A-Go-Go Potassium Channels) RN - 0 (KCNH2 protein, human) RN - 0 (Phenethylamines) RN - 0 (Potassium Channel Blockers) RN - 0 (Sulfonamides) RN - R4Z9X1N2ND (dofetilide) SB - IM MH - DNA, Complementary/genetics MH - ERG1 Potassium Channel MH - Ether-A-Go-Go Potassium Channels/*genetics MH - Fluorometry MH - HEK293 Cells MH - Humans MH - Long QT Syndrome/congenital/*genetics MH - Mutation MH - Patch-Clamp Techniques/methods MH - Phenethylamines/pharmacology MH - Potassium Channel Blockers/pharmacology MH - Protein Transport MH - Sulfonamides/pharmacology MH - Transfection EDAT- 2011/03/08 06:00 MHDA- 2012/01/19 06:00 CRDT- 2011/03/08 06:00 PHST- 2010/08/20 00:00 [received] PHST- 2011/02/24 00:00 [accepted] PHST- 2011/03/08 06:00 [entrez] PHST- 2011/03/08 06:00 [pubmed] PHST- 2012/01/19 06:00 [medline] AID - S1547-5271(11)00256-6 [pii] AID - 10.1016/j.hrthm.2011.02.035 [doi] PST - ppublish SO - Heart Rhythm. 2011 Aug;8(8):1273-80. doi: 10.1016/j.hrthm.2011.02.035. Epub 2011 Mar 3.